DDDay One Biopharmaceuticals, Inc.
6.64USDR
−0.03−0.45%
Last update at Jun 16, 22:54 GMT
USD
No tradesPre-market
Price target
28.00RUSD+21.36+321.69%
The 8 analysts offering 1 year price forecasts for Day One Biopharmaceuticals, Inc. have a max estimate of 36.00 and a min estimate of 20.00.
Analyst rating
Based on 9 analysts giving stock ratings to Day One Biopharmaceuticals, Inc. in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
8
Buy
0
Hold
1
Sell
0
Strong sell
0
EPS
Forecast
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
−0.80
−0.40
0.00
0.40
0.80
Reported
Estimate
Currency: USD
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Reported
−0.54
−0.63
−0.72
−0.05
0.38
−0.63
−0.35
—
—
—
—
Estimate
−0.59
−0.57
−0.66
−0.75
−0.32
−0.36
−0.44
−0.35
−0.33
−0.33
−0.30
Surprise
+7.80%
−9.68%
−8.58%
+93.34%
+220.42%
−73.81%
+20.07%
—
—
—
—
Revenue
Forecast
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
0.00
25.00 M
50.00 M
75.00 M
100.00 M
Reported
Estimate
Currency: USD
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Reported
0.00
0.00
0.00
8.19 M
93.76 M
29.20 M
30.76 M
—
—
—
—
Estimate
0.00
0.00
0.00
1.03 M
28.48 M
27.83 M
30.27 M
35.56 M
40.01 M
44.62 M
53.63 M
Surprise
—
—
—
+698.25%
+229.17%
+4.92%
+1.63%
—
—
—
—
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
DAWN EPS for the last quarter is −0.35 USD despite the estimation of −0.44 USD. In the next quarter EPS is expected to reach −0.35 USD. Track more of Day One Biopharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Day One Biopharmaceuticals, Inc. revenue is expected to reach 35.56 M USD. Check out Day One Biopharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, DAWN price target is 28.00 USD with a max estimate of 36.00 USD and a min estimate of 20.00 USD. Check if this forecast comes true in a year, meanwhile watch Day One Biopharmaceuticals, Inc. stock price chart and keep track of the current situation with DAWN news and stock market news.
We've gathered opinions of 9 analysts rating DAWN stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.